Design and synthesis of novel, conformationally restricted HMG-CoA reductase inhibitors
摘要:
Using structure-based design, a novel series of conformationally restricted, pyrrole-based inhibitors of HMG-CoA reductase were discovered. Leading analogs demonstrated potent inhibition of cholesterol synthesis in both in vitro and in vivo models and may be useful for the treatment of hypercholesterolemia and related lipid disorders. (c) 2007 Elsevier Ltd. All rights reserved.
Design and synthesis of novel, conformationally restricted HMG-CoA reductase inhibitors
摘要:
Using structure-based design, a novel series of conformationally restricted, pyrrole-based inhibitors of HMG-CoA reductase were discovered. Leading analogs demonstrated potent inhibition of cholesterol synthesis in both in vitro and in vivo models and may be useful for the treatment of hypercholesterolemia and related lipid disorders. (c) 2007 Elsevier Ltd. All rights reserved.
[EN] FUSED BICYCLIC PYRROLS AS HMG-COA REDUCTASE INHIBITORS<br/>[FR] PYRROLS BICYCLIQUES FUSIONNES COMME INHIBITEURS DE LA REDUCTASE AS HMG-COA
申请人:WARNER LAMBERT CO
公开号:WO2006059210A2
公开(公告)日:2006-06-08
[EN] HMGCo-A reductase inhibitor compounds useful as hypocholesterolemic and hypolipidenuc compounds are provided. Also provided are pharmaceutical compositions of the compounds. Methods of making and methods of using the compounds are also provided. [FR] Composés de l'inhibiteur de la réductase HMGCo-A utilisés comme composés hypocholestérolémiques et hypolipidémiques. Compositions pharmaceutiques de ces composés, leurs procédés de préparation et d'utilisation.